Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
Cardiovascular device division of Medtronic.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New valve replacement could fix leaky hearts without cutting chest open Results expected Sep 2026 (estimated)
- Which stent graft shrinks aneurysms best? new trial aims to find out. Results expected May 2027 (estimated)
- New heart valve device offers hope for patients too sick for surgery Results expected Jun 2027 (estimated)
- New heart valve study aims to fix leaky valve without Open-Heart surgery Results expected Jul 2027 (estimated)
- New hope for heart patients: less invasive valve procedure tested for moderate stenosis Results expected Sep 2027 (estimated)
-
New heart valve procedure offers hope for patients too sick for surgery
Disease control CompletedThis study tested a new way to replace a narrowed heart valve without open-heart surgery. It involved 782 people with severe aortic stenosis who were considered too high-risk for traditional surgery. The procedure, called TAVI, uses a thin tube to place a new valve inside the hea…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New anchor device aims to secure aortic aneurysm repairs
Disease control CompletedThis registry tracked over 1,000 patients who received the Heli-FX EndoAnchor device during endovascular repair of aortic aneurysms. The device is designed to help hold the endograft in place and prevent leaks. Patients were followed for up to 5 years to see how safe and effectiv…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New heart valve study aims to cut complications in aortic stenosis patients
Disease control CompletedThis study tested an optimized care plan for people with a narrowed aortic heart valve who received a new valve through a catheter (TAVR). Over 1,100 patients were enrolled to see if the improved care pathway could lower risks like death, stroke, and the need for a pacemaker. The…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New heart valve shows promise for High-Risk patients
Disease control CompletedThis study tested a new heart valve called Evolut PRO in 638 people with severe aortic stenosis who were at high risk for open-heart surgery. The valve was implanted using a thin tube through an artery, avoiding major surgery. Results showed that only 3.3% of patients died within…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 26, 2026 14:57 UTC